Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice

Canine leptospirosis in Canada: a veterinarian's perspective

John Prescott
CMAJ February 12, 2008 178 (4) 397-398; DOI: https://doi.org/10.1503/cmaj.071092
John Prescott VetMB PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
  • © 2008 Canadian Medical Association

Leptospirosis is a zoonotic bacterial disease that appears to be becoming more prevalent in Canada. The number of cases of leptospirosis in dogs in Canada and the United States has increased markedly in the last decade.1–10 Transmission to humans is rare, although a few human cases in which leptospirosis was acquired from dogs have been recently recognized in Ontario and Quebec.7,10

Between 1998 and 2005, the number of canine sera samples submitted to the Animal Health Laboratory at the University of Guelph for leptospirosis serologic testing increased from 42 to 1136. In 2005, 251 samples (22%) were positive for leptospirosis and 404 (36%) were “suspicious.”6 There has been no change in laboratory diagnostic procedures over this time, so the increases in cases may reflect increased awareness and, more concerningly, a true increase in the incidence and level of disease activity in Ontario. There has been a similar trend Quebec, where the number of positive canine serodiagnoses rose from 5 in 1998 to 56 in 2006.7 The number of canine cases has also increased in New Brunswick (Dr James Goltz, New Brunswick Ministry of Agriculture and Aquaculture, personal communication, 2005). Although few cases have been documented in British Columbia, diagnoses of canine leptospirosis have increased recently in nearby Washington State, particularly in the greater Seattle area.8 Currently the Prairie provinces report few case of canine leptospirosis. In Canada, dogs are usually tested for the following leptospirosis serotypes: autumnalis, bratislava, canicola, icterohemorrhagiae, grippotyphosa and pomona. However, these tests may not identify the infecting serotype because in acute canine leptospirosis, there is often a confusing pattern of cross-reactivity against multiple serotypes.1,5,6

Canine leptospirosis can affect dogs in both urban and suburban environments. Wild and domestic animals, including raccoons, skunks, dogs and rats, can act as reservoirs. The increased number of cases observed in certain parts of Canada likely relates to a combination of increased infection among the large number of raccoons that inhabit urban and suburban settings, ecological conditions brought about by a warming climate that favours the survival of this fastidious organism and increased awareness of the infection by veterinarians.1 Leptospirosis in Canadian dogs occurs largely in the fall (September–December) when the weather is both warm and wet. The infecting serotypes observed more recently in North American dogs are largely grippotyphosa and pomona, which are acquired from urban raccoons and skunks. In contrast, the serotypes canicola and icterohemorrhagiae are acquired from dogs and rats respectively. These emerging trends suggest that the epidemiology of infection, including the infecting serotypes and the role of raccoons, needs to be clarified.

Leptospirosis in dogs can be a very serious disease, and the disease may present as peracute, acute, subacute or chronic (Box 1).3,4 Subacute disease is the most commonly recognized form of the disease, but many leptospiral infections in dogs are chronic and the majority are probably subclinical. Unlike humans, aseptic meningitis is not recognized. An additional diagnostic challenge to veterinarians, is the failure (because of cost) to obtain a “convalescent” serum sample.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 1.

Dogs are thought to shed wildlife-acquired leptospires in their urine for up to 6 weeks after infection, although they will shed the dog-adapted serotype canicola for life. Thus, people are at risk for infection not only from dogs who are obviously sick but also from subclinically infected animals who appear healthy. Fortunately, the canicola serotype has been largely eradicated by canine vaccination.

A “4-way” vaccine for dogs that includes the serotypes grippotyphosa and pomona was introduced in Canada in 2001. Annual vaccination controls these infections effectively and is increasingly recommended by many veterinarians. The extent of vaccination coverage and its population effect (herd immunity) has not been documented.

The increased level of disease activity among dogs prompts questions about increased risk of transmission to humans. Recently, there have been reports of small numbers of cases of infections acquired from dogs by veterinary staff10 and by the owners of infected dogs.7,9,10 Unfortunately, documentation has been poor. The overall prevalence appears still to be very low, although no population surveys have been done. A recent case of a family's exposure to an infected pet, which was brought to the attention of a local public health unit, prompted the accompanying Public Health column on leptospirosis.11

Perhaps because of the lack of awareness of leptospirosis among Canadian physicians and the relative rarity of human cases in Canada, a few of the recognized cases involved self-diagnosis or diagnosis by veterinarians9 and subsequent confirmation by health care professionals. Canadian physicians need to be aware of the risk that canine leptospirosis acquired from urban wildlife, notably raccoons, poses to humans. It would be a useful if veterinarians were required to report canine cases of leptospirosis to public health authorities. This may improve understanding about the level of risk and possibly assist in the detection and prevention of secondary human cases. Mandatory reporting would likely increase veterinary attempts to control the canine (and therefore human) infection by vaccination, and it would increase medical awareness of this problem.

@ See related article page 399

Key points of the article

• There has been a marked increase in canine leptospirosis in North America in the last decade.

• Suburban raccoons may be a reservoir.

• Climate change may enhance bacterial survival.

• An effective canine vaccine is available to control wildlife-acquired serotypes.

• Reporting of canine leptospirosis should be mandatory.

Footnotes

  • This article has been peer reviewed.

    Competing interests: None declared.

REFERENCES

  1. 1.↵
    Prescott JF, McEwen B, Taylor J, et al. Resurgence of leptospirosis in dogs in Ontario: recent findings. Can Vet J 2002;43:955-61.
    OpenUrlPubMed
  2. 2.
    Ward MP, Glickman LT, Guptill LE. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). J Am Vet Med Assoc 2002;220:53-8.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Greene CE, Sykes JE, Brown CA, et al. Leptospirosis. In: Greene CE, editors. Infectious diseases of the dog and cat. 3rd ed. St. Louis (MO): WB Saunders; 2006. p. 402-17.
  4. 4.↵
    Langston CE, Heuter KJ. Leptospirosis: a re-emerging zoonotic disease. Emerging and Re-emerging Infectious Diseases. Vet Clin North Am Small Anim Pract 2003;33:791-807.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Moore GE, Guptill LF, Glickman NW, et al. Canine leptospirosis, United States, 2002–2004. Emerg Infect Dis 2006;12:501-3.
    OpenUrlPubMed
  6. 6.↵
    McEwen B, Ojkic D, Prescott JF. Canine leptospirosis update. Animal Health Laboratory Newsletter. Issue 10. Guelph (ON): The University of Guelph; 2006. p. 24. Available: www.labservices.uoguelph.ca/labserv/units/ahl/files/ANwsl10-3.pdf (accessed 2007 Dec 12).
  7. 7.↵
    Vincent C, Munger C, Labrecque O, et al. La leptospirose: Cas de transmission d'un chien à un humain. Réseau d'Alerte et d'Information Zoosanitaire (RAIZO) Bulletin Zoosanitaire [no.51]. The Bulletin; 2007. Available: www.mapaq.gouv.qc.ca/NR/rdonlyres/F1DE44C9-4DBD-40D8-96BF-E4CCBBF33646/0/BulletinLeptocanine2006_51.pdf (accessed 2007 Dec 12).
  8. 8.↵
    Leslie M, Baer R. Increase in reported human and canine leptospirosis in Washington. Washington: Washington State Department of Health. Available: www.doh.wa.gov/EHSPHL/Epidemiology/CD/ci/caninelepto.htm (accessed 2007 Dec 12).
  9. 9.↵
    Wyeth Animal Health. Leptospirosis Information. www.leptoinfo.com/User/Docs/Leptoinfo.comLepto%20Health%20&%20Safety%20Bulletin.pdf (accessed 2008 Jan 9).
  10. 10.↵
    Allard R, Bédard L. Explanatory notes on statistics for reportable disease (Maladies infectieuses à déclaration obligitaire) and other infectious diseases under surveillance, period 3, year 2006 (weeks 9-12 [26 February 2006 to 25 March 2006). Montréal, Que: Montréal Public Health Department; 2006. Available: www.santepub-mtl.qc.ca/Mi/surveillance/mado/archives/english/2006/notes2006.pdf (accessed 2008 Jan 9).
  11. 11.↵
    Brown K, Prescott J. Leptospirosis in the family dog: a public health perspective. CMAJ 2008;178:399-401.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 178 (4)
CMAJ
Vol. 178, Issue 4
12 Feb 2008
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Canine leptospirosis in Canada: a veterinarian's perspective
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Canine leptospirosis in Canada: a veterinarian's perspective
John Prescott
CMAJ Feb 2008, 178 (4) 397-398; DOI: 10.1503/cmaj.071092

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Canine leptospirosis in Canada: a veterinarian's perspective
John Prescott
CMAJ Feb 2008, 178 (4) 397-398; DOI: 10.1503/cmaj.071092
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • Leptospirosis in the family dog: a public health perspective
  • PubMed
  • Google Scholar

Cited By...

  • A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs
  • Google Scholar

More in this TOC Section

  • SARS-CoV-2 vaccination in pregnancy
  • Infantile perianal pyramidal protrusion
  • Topical nonsteroidal anti-inflammatory drugs
Show more Practice

Similar Articles

Collections

  • Topics
    • Family medicine, general practice, primary care
    • Infectious diseases

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire